|4Oct 16, 6:07 PM ET

Squadron Capital LLC 4

4 · ORTHOPEDIATRICS CORP · Filed Oct 16, 2017

Insider Transaction Report

Form 4
Period: 2017-10-16
Transactions
  • Conversion

    Common Stock

    2017-10-16+1,920,0625,378,441 total
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-161,000,0000 total
    Common Stock (670,000 underlying)
  • Conversion

    Common Stock

    2017-10-16+3,455,8333,458,379 total
  • Conversion

    Series B Convertible Preferred Stock

    2017-10-164,157,9600 total
    Common Stock (2,785,833 underlying)
Footnotes (3)
  • [F1]Represents shares received upon conversion of the Series A Convertible Preferred Stock and the Series B Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering.
  • [F2]Represents shares received upon conversion of a $16.0 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering.
  • [F3]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock).

Documents

1 file
  • 4
    tv477024_4.xmlPrimary

    FORM 4